ATE380346T1 - Differentialdiagnose von störungen vom eisenmetabolismus - Google Patents

Differentialdiagnose von störungen vom eisenmetabolismus

Info

Publication number
ATE380346T1
ATE380346T1 AT02777081T AT02777081T ATE380346T1 AT E380346 T1 ATE380346 T1 AT E380346T1 AT 02777081 T AT02777081 T AT 02777081T AT 02777081 T AT02777081 T AT 02777081T AT E380346 T1 ATE380346 T1 AT E380346T1
Authority
AT
Austria
Prior art keywords
iron metabolism
differential diagnosis
metabolism disorders
disorders
iron
Prior art date
Application number
AT02777081T
Other languages
English (en)
Inventor
Ralf Roeddiger
Paul Lehmann
Lothar Thomas
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE380346T1 publication Critical patent/ATE380346T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/90—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving iron binding capacity of blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Control Of Steam Boilers And Waste-Gas Boilers (AREA)
  • Coating With Molten Metal (AREA)
  • Investigating And Analyzing Materials By Characteristic Methods (AREA)
  • Investigating Or Analyzing Materials By The Use Of Magnetic Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT02777081T 2001-09-14 2002-09-12 Differentialdiagnose von störungen vom eisenmetabolismus ATE380346T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32252601P 2001-09-14 2001-09-14

Publications (1)

Publication Number Publication Date
ATE380346T1 true ATE380346T1 (de) 2007-12-15

Family

ID=23255267

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02777081T ATE380346T1 (de) 2001-09-14 2002-09-12 Differentialdiagnose von störungen vom eisenmetabolismus

Country Status (8)

Country Link
US (1) US7601684B2 (de)
EP (1) EP1425589B1 (de)
JP (1) JP2005503559A (de)
AT (1) ATE380346T1 (de)
CA (1) CA2459972A1 (de)
DE (1) DE60223931T2 (de)
ES (2) ES2399110T3 (de)
WO (1) WO2003025583A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7459435B2 (en) * 2002-08-29 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
US7459436B2 (en) * 2002-11-22 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
DE10349124A1 (de) 2003-10-22 2005-05-19 Roche Diagnostics Gmbh Differenzialdiagnostik mit Hepcidin
JP2007514673A (ja) 2003-12-19 2007-06-07 エフ．ホフマン−ラ　ロシュ　アーゲー 慢性炎症性腸疾患の際の鉄分布障害の処置におけるエリスロポエチンの使用
JP2008523068A (ja) * 2004-12-08 2008-07-03 ノバルティス アクチエンゲゼルシャフト 有機化合物の使用
US7586589B2 (en) * 2005-09-24 2009-09-08 Beckman Coulter, Inc. Methods of determination of responsiveness to erythropoietin treatment
WO2007084976A2 (en) * 2006-01-20 2007-07-26 Beckman Coulter, Inc. Methods of detection of iron deficiency
JP4949898B2 (ja) * 2007-03-09 2012-06-13 シスメックス株式会社 血球分析装置
WO2011057744A1 (en) 2009-11-13 2011-05-19 Roche Diagnostics Gmbh Differential diagnosis of iron deficiencies based on hepcidin and mean hemoglobin content per reticulocyte
JP5868982B2 (ja) * 2010-09-16 2016-02-24 ザ ジェネラル ホスピタル コーポレイション 診断のための赤血球動力学
US10955423B2 (en) 2015-12-15 2021-03-23 The General Hospital Corporation Methods of estimating blood glucose and related systems
GB201604806D0 (en) * 2016-03-22 2016-05-04 Singapore Volition Pte Ltd Method of identifying a cancer of unknown origin
US11293852B2 (en) 2016-04-07 2022-04-05 The General Hospital Corporation White blood cell population dynamics
CN115244074A (zh) * 2020-02-11 2022-10-25 奎斯特诊断投资有限责任公司 确定贫血的潜在病因的系统
WO2022102734A1 (ja) * 2020-11-13 2022-05-19 株式会社堀場製作所 血液検体の判定方法、そのための判定装置とコンピュータープログラム

Also Published As

Publication number Publication date
EP1425589A2 (de) 2004-06-09
WO2003025583A2 (en) 2003-03-27
ES2297011T3 (es) 2008-05-01
WO2003025583A3 (en) 2003-12-18
US7601684B2 (en) 2009-10-13
ES2399110T3 (es) 2013-03-25
JP2005503559A (ja) 2005-02-03
EP1425589B1 (de) 2007-12-05
CA2459972A1 (en) 2003-03-27
DE60223931D1 (de) 2008-01-17
US20030073635A1 (en) 2003-04-17
DE60223931T2 (de) 2008-04-03

Similar Documents

Publication Publication Date Title
ATE380346T1 (de) Differentialdiagnose von störungen vom eisenmetabolismus
ATE440537T1 (de) Vorrichtungen zum auffangen von interessierenden analyten in tränen
WO2005037203A3 (en) Methods and reagents for the treatment of immunoinflammatory disorders
EP1883349A4 (de) Verfahren und gerät zur diagnose von atemwegserkrankungen und zur bestimmung des exacerbationsgrades
EP1781303A4 (de) Verfahren und reagentien zur behandlung von stoffwechselerkrankungen
SG146653A1 (en) Methods and reagents for the treatment of immunoinflammatory disorders
ATE442592T1 (de) Detektion und/oder beobachtung von synuclein- assoziierten krankheiten
CY1109985T1 (el) Αναστολεις πρωτεασωματος και μεθοδοι χρησης αυτων
CY1115059T1 (el) Θεραπευτικα απταμερη χρησιμα στην θεραπευτικη αγωγη διαταραχων σχετιζομενων με συμπληρωμα
IS8071A (is) Aðferð við meðhöndlun á hnútahersli, fitudreyra og tengdum ástands tegundum og lyfjafræðilegum samsetningum
BR0313792A (pt) Utilização de proteìna de eritropoetina, método para tratamento de distúrbios de distribuição de ferro em diabetes e medicamento para o seu tratamento
DK1436427T3 (da) Fremgangsmåde og sammensætning til at vurdere antistofbehandlingsrespons
EP1948280A4 (de) Biliäre/pankreatisches shunt-vorrichtung und verfahren zur behandlung von metabolischen und anderen erkrankungen
NO20071378L (no) Tiazolo-naftylsyrer.
IL188036A0 (en) Methods and apparatus for improving the sensitivity of capillary zone electrophoresis
WO2004107958A3 (en) Sterol markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease
WO2006074450A3 (en) Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases
DE602008004556D1 (de) Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin
DE60232913D1 (de) Diagnose und behandlung von atherosklerose
EP1865778A4 (de) Verfahren zur vermeidung von ödem bei der behandlung von stoffwechselstörungen, entzündlichen erkrankungen und herz-kreislauf-erkrankungen
EP1909106A3 (de) Differenzialdiagnose von Eisenstoffwechselstörungen mittels dreier unabhängiger Parameter und Empfehlungen für die Behandlung dieser Eisenstoffwechselstörungen
WO2007067512A3 (en) Method for identifying modulators of adprh useful for treating alzheimer's disease
DE602005026260D1 (de) Natürliche igm-antikörper und inhibitoren davon
EP1852442A4 (de) Antikörper für einen assay auf die adamts13-aktivität und aktivitätsessayverfahren
DE602006020576D1 (de) Verfahren zur gliomdiagnose mit unterscheidung zwischen progressiven und de-novo-formen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1425589

Country of ref document: EP